Company intelligence / Profile preview

Maokang

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Maokang Biotechnology is a life sciences company focused on providing high-quality research reagents and technical services to the global scientific community. The company's product portfolio includes recombinant proteins, antibodies, molecular biology kits, and biochemical reagents tailored for proteomics and genomics applications. In addition to its product offerings, Maokang provides specialized CRO services such as custom protein expression, antibody development, and cell line engineering. Based in Shanghai, the company supports drug discovery and basic research across various therapeutic areas including oncology and immunology. Its products are widely used in academic laboratories and pharmaceutical R&D centers.

Modalities: Recombinant proteinMonoclonal antibodySmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Maokang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maokang.

Explore the full profile